Novo Nordisk has seen a 15.33% surge over the past month, outperforming the Medical sector and the S&P 500.The company is expected to announce an EPS of $0.9 and revenue of$12.11 billion in its upcoming earnings report.Novo Nordisk's stock has experienced significant volatility, with a 52-week high of $93.80 and a low of$43.08.Novo Nordisk (NYSE:NVO) is a global healthcare company known for its leadership in diabetes care. The company also focuses on other serious chronic conditions such as obesity and ra ...